… intervention on mortality and morbidity in heart failure patients 3, 4. … heart failure patients and
their effects on clinical outcomes … and outcomes in a large sample of heart failure patients in …

… with recommended pharmacotherapy is a common problem in heart failure and may …
pharmacotherapy in 107 092 patients discharged after first hospitalization for heart failure in …

… points to an earlier onset of heart failure in Asian than in western populations. With
pharmacotherapy being the mainstay in the management of heart failure, our findings have major …

… medications and outcomes in patients with heart failure (HF) and renal dysfunction. … Crude
one-year mortality rates in 3,914 patients with cardiologistassigned diagnosis of heart failure, …

… heart failure, and their beneficial effect is unlikely to differ according to renal function.
Spironolactone improves outcomes in patients with advanced heart failure, … in heart failure should …

… contemporary HFrEF pharmacotherapy and reporting HRQoL as an outcome were included.
Two … The primary outcome was HRQoL at last available follow-up analysed using a random-…

… United States describing pharmacotherapy treatment patterns, … pharmacotherapy treatment
patterns, resource utilization and associated charges, and morbidity and mortality outcomes …

… The primary outcomes of this study will be the change over 6 months in myocardial
inflammation and fibrosis measured by cardiac MRI and the left atrial volume index measured by …

… left ventricular systolic function in heart failure patients ( 27 ). … adverse hemodynamic changes
in heart failure patients ( 17 )… blockers had a history of heart failure in this study population…

… Our results suggest that increasing adherence to heart failure medications measured as a
10% increment has a favorable effect on health outcomes including reducing mortality by 9% (…